Magenta Therapeutics
Jul 31, 2020
A Complex Chromosomal Abberation Called Adrenoleukodystrophy
The global Adrenoleukodystrophy market size for the forecast period 2020-30, which was estimated to be USD 922.43 million in the 7MM in 2017 is driven by key pharma players such as Bluebird Bio, Minoryx Therapeutics, MedDay Pharmaceuticals, Magenta Therapeutics, and others are proactively focusing on advancing ALD ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
